rnascope probes Search Results


high-risk hpv rnascope probe  (ProPath Laboratory Inc)
90
ProPath Laboratory Inc high-risk hpv rnascope probe
High Risk Hpv Rnascope Probe, supplied by ProPath Laboratory Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/high-risk hpv rnascope probe/product/ProPath Laboratory Inc
Average 90 stars, based on 1 article reviews
high-risk hpv rnascope probe - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
refseq, reviewed or unreviewed sequences of hrhpv oncoproteins (e5, e6, and e7)  (Biotechnology Information)
90
Biotechnology Information refseq, reviewed or unreviewed sequences of hrhpv oncoproteins (e5, e6, and e7)
Refseq, Reviewed Or Unreviewed Sequences Of Hrhpv Oncoproteins (E5, E6, And E7), supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/refseq, reviewed or unreviewed sequences of hrhpv oncoproteins (e5, e6, and e7)/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
refseq, reviewed or unreviewed sequences of hrhpv oncoproteins (e5, e6, and e7) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
rnascope probe-rn-cdkn2a  (Cosmo Bio USA)
90
Cosmo Bio USA rnascope probe-rn-cdkn2a
Senescent satellite cells and mesenchymal progenitor cells were present in DMD rats. ( a – c ) Quantification of mRNA levels of senescence markers (p16, p19, and p21) in WT and DMD rat TA muscles (n = 6, each). ( d ) In situ hybridisation of <t>CDKN2A</t> mRNA using RNAscope on TA muscle sections from 6-month-old WT and DMD rats. Shown are representative images of tissues from WT (top) and DMD rats (middle) with CDKN2A mRNA appearing as brown dots. Scale bar = 50 μm. A higher magnification image from the dotted area is shown in the bottom frame. Scale bar = 10 μm. The white arrowheads show the mononucleated CDKN2A mRNA + cells. ( e ) Skeletal muscle primary cells from 6-month-old DMD rats were subjected to CDKN2A mRNA in situ hybridisation using RNAscope before the immunocytochemistry of Pax7, CSPG4, CD45, and CD31. Scale bar = 10 μm. White arrowheads indicate DAB signal. White arrows indicate CD45 + or CD31 + cells. ( f ) Quantification of CDKN2A + Pax7 + cells per all Pax7 + cells (shown as SC) and CDKN2A + CSPG4 + cells per all CSPG4 + cells (shown as MPC) in skeletal muscle primary cells from DMD rats (n = 4, each). Data are expressed as mean + SEM, and were compared by Tukey Kramer’s test. For ( a – c ), the result of statistical comparison only between the genotypes at each indicated ages was displayed. When a significant age-related difference was observed by the Tukey–Kramer’s test, the † mark was added beside the legend of the graph. *p < 0.05. **p < 0.01. ***p < 0.001.
Rnascope Probe Rn Cdkn2a, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rnascope probe-rn-cdkn2a/product/Cosmo Bio USA
Average 90 stars, based on 1 article reviews
rnascope probe-rn-cdkn2a - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
smfish and rnascope stellaris® fish probes  (LGC Biosearch)
90
LGC Biosearch smfish and rnascope stellaris® fish probes
Senescent satellite cells and mesenchymal progenitor cells were present in DMD rats. ( a – c ) Quantification of mRNA levels of senescence markers (p16, p19, and p21) in WT and DMD rat TA muscles (n = 6, each). ( d ) In situ hybridisation of <t>CDKN2A</t> mRNA using RNAscope on TA muscle sections from 6-month-old WT and DMD rats. Shown are representative images of tissues from WT (top) and DMD rats (middle) with CDKN2A mRNA appearing as brown dots. Scale bar = 50 μm. A higher magnification image from the dotted area is shown in the bottom frame. Scale bar = 10 μm. The white arrowheads show the mononucleated CDKN2A mRNA + cells. ( e ) Skeletal muscle primary cells from 6-month-old DMD rats were subjected to CDKN2A mRNA in situ hybridisation using RNAscope before the immunocytochemistry of Pax7, CSPG4, CD45, and CD31. Scale bar = 10 μm. White arrowheads indicate DAB signal. White arrows indicate CD45 + or CD31 + cells. ( f ) Quantification of CDKN2A + Pax7 + cells per all Pax7 + cells (shown as SC) and CDKN2A + CSPG4 + cells per all CSPG4 + cells (shown as MPC) in skeletal muscle primary cells from DMD rats (n = 4, each). Data are expressed as mean + SEM, and were compared by Tukey Kramer’s test. For ( a – c ), the result of statistical comparison only between the genotypes at each indicated ages was displayed. When a significant age-related difference was observed by the Tukey–Kramer’s test, the † mark was added beside the legend of the graph. *p < 0.05. **p < 0.01. ***p < 0.001.
Smfish And Rnascope Stellaris® Fish Probes, supplied by LGC Biosearch, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/smfish and rnascope stellaris® fish probes/product/LGC Biosearch
Average 90 stars, based on 1 article reviews
smfish and rnascope stellaris® fish probes - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
rnascope probes  (Sun Pharma)
90
Sun Pharma rnascope probes
Senescent satellite cells and mesenchymal progenitor cells were present in DMD rats. ( a – c ) Quantification of mRNA levels of senescence markers (p16, p19, and p21) in WT and DMD rat TA muscles (n = 6, each). ( d ) In situ hybridisation of <t>CDKN2A</t> mRNA using RNAscope on TA muscle sections from 6-month-old WT and DMD rats. Shown are representative images of tissues from WT (top) and DMD rats (middle) with CDKN2A mRNA appearing as brown dots. Scale bar = 50 μm. A higher magnification image from the dotted area is shown in the bottom frame. Scale bar = 10 μm. The white arrowheads show the mononucleated CDKN2A mRNA + cells. ( e ) Skeletal muscle primary cells from 6-month-old DMD rats were subjected to CDKN2A mRNA in situ hybridisation using RNAscope before the immunocytochemistry of Pax7, CSPG4, CD45, and CD31. Scale bar = 10 μm. White arrowheads indicate DAB signal. White arrows indicate CD45 + or CD31 + cells. ( f ) Quantification of CDKN2A + Pax7 + cells per all Pax7 + cells (shown as SC) and CDKN2A + CSPG4 + cells per all CSPG4 + cells (shown as MPC) in skeletal muscle primary cells from DMD rats (n = 4, each). Data are expressed as mean + SEM, and were compared by Tukey Kramer’s test. For ( a – c ), the result of statistical comparison only between the genotypes at each indicated ages was displayed. When a significant age-related difference was observed by the Tukey–Kramer’s test, the † mark was added beside the legend of the graph. *p < 0.05. **p < 0.01. ***p < 0.001.
Rnascope Probes, supplied by Sun Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rnascope probes/product/Sun Pharma
Average 90 stars, based on 1 article reviews
rnascope probes - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
in situ hybridization kit rnascope target probe - hs- slc2a2  (Cosmo Bio USA)
90
Cosmo Bio USA in situ hybridization kit rnascope target probe - hs- slc2a2
Senescent satellite cells and mesenchymal progenitor cells were present in DMD rats. ( a – c ) Quantification of mRNA levels of senescence markers (p16, p19, and p21) in WT and DMD rat TA muscles (n = 6, each). ( d ) In situ hybridisation of <t>CDKN2A</t> mRNA using RNAscope on TA muscle sections from 6-month-old WT and DMD rats. Shown are representative images of tissues from WT (top) and DMD rats (middle) with CDKN2A mRNA appearing as brown dots. Scale bar = 50 μm. A higher magnification image from the dotted area is shown in the bottom frame. Scale bar = 10 μm. The white arrowheads show the mononucleated CDKN2A mRNA + cells. ( e ) Skeletal muscle primary cells from 6-month-old DMD rats were subjected to CDKN2A mRNA in situ hybridisation using RNAscope before the immunocytochemistry of Pax7, CSPG4, CD45, and CD31. Scale bar = 10 μm. White arrowheads indicate DAB signal. White arrows indicate CD45 + or CD31 + cells. ( f ) Quantification of CDKN2A + Pax7 + cells per all Pax7 + cells (shown as SC) and CDKN2A + CSPG4 + cells per all CSPG4 + cells (shown as MPC) in skeletal muscle primary cells from DMD rats (n = 4, each). Data are expressed as mean + SEM, and were compared by Tukey Kramer’s test. For ( a – c ), the result of statistical comparison only between the genotypes at each indicated ages was displayed. When a significant age-related difference was observed by the Tukey–Kramer’s test, the † mark was added beside the legend of the graph. *p < 0.05. **p < 0.01. ***p < 0.001.
In Situ Hybridization Kit Rnascope Target Probe Hs Slc2a2, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/in situ hybridization kit rnascope target probe - hs- slc2a2/product/Cosmo Bio USA
Average 90 stars, based on 1 article reviews
in situ hybridization kit rnascope target probe - hs- slc2a2 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Senescent satellite cells and mesenchymal progenitor cells were present in DMD rats. ( a – c ) Quantification of mRNA levels of senescence markers (p16, p19, and p21) in WT and DMD rat TA muscles (n = 6, each). ( d ) In situ hybridisation of CDKN2A mRNA using RNAscope on TA muscle sections from 6-month-old WT and DMD rats. Shown are representative images of tissues from WT (top) and DMD rats (middle) with CDKN2A mRNA appearing as brown dots. Scale bar = 50 μm. A higher magnification image from the dotted area is shown in the bottom frame. Scale bar = 10 μm. The white arrowheads show the mononucleated CDKN2A mRNA + cells. ( e ) Skeletal muscle primary cells from 6-month-old DMD rats were subjected to CDKN2A mRNA in situ hybridisation using RNAscope before the immunocytochemistry of Pax7, CSPG4, CD45, and CD31. Scale bar = 10 μm. White arrowheads indicate DAB signal. White arrows indicate CD45 + or CD31 + cells. ( f ) Quantification of CDKN2A + Pax7 + cells per all Pax7 + cells (shown as SC) and CDKN2A + CSPG4 + cells per all CSPG4 + cells (shown as MPC) in skeletal muscle primary cells from DMD rats (n = 4, each). Data are expressed as mean + SEM, and were compared by Tukey Kramer’s test. For ( a – c ), the result of statistical comparison only between the genotypes at each indicated ages was displayed. When a significant age-related difference was observed by the Tukey–Kramer’s test, the † mark was added beside the legend of the graph. *p < 0.05. **p < 0.01. ***p < 0.001.

Journal: Scientific Reports

Article Title: Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy

doi: 10.1038/s41598-020-73315-6

Figure Lengend Snippet: Senescent satellite cells and mesenchymal progenitor cells were present in DMD rats. ( a – c ) Quantification of mRNA levels of senescence markers (p16, p19, and p21) in WT and DMD rat TA muscles (n = 6, each). ( d ) In situ hybridisation of CDKN2A mRNA using RNAscope on TA muscle sections from 6-month-old WT and DMD rats. Shown are representative images of tissues from WT (top) and DMD rats (middle) with CDKN2A mRNA appearing as brown dots. Scale bar = 50 μm. A higher magnification image from the dotted area is shown in the bottom frame. Scale bar = 10 μm. The white arrowheads show the mononucleated CDKN2A mRNA + cells. ( e ) Skeletal muscle primary cells from 6-month-old DMD rats were subjected to CDKN2A mRNA in situ hybridisation using RNAscope before the immunocytochemistry of Pax7, CSPG4, CD45, and CD31. Scale bar = 10 μm. White arrowheads indicate DAB signal. White arrows indicate CD45 + or CD31 + cells. ( f ) Quantification of CDKN2A + Pax7 + cells per all Pax7 + cells (shown as SC) and CDKN2A + CSPG4 + cells per all CSPG4 + cells (shown as MPC) in skeletal muscle primary cells from DMD rats (n = 4, each). Data are expressed as mean + SEM, and were compared by Tukey Kramer’s test. For ( a – c ), the result of statistical comparison only between the genotypes at each indicated ages was displayed. When a significant age-related difference was observed by the Tukey–Kramer’s test, the † mark was added beside the legend of the graph. *p < 0.05. **p < 0.01. ***p < 0.001.

Article Snippet: Then, the samples were hybridised with RNAscope Probe-Rn-CDKN2A (for rat samples; Cosmo Bio) or RNAscope Probe-Hs-CDKN2A (for human samples; Cosmo Bio) for 2 h, and signals were amplified with AMP1 to 6 (Cosmo Bio).

Techniques: In Situ, Hybridization, Immunocytochemistry

Senolytic drug ABT263 inhibits the exacerbation of muscular dystrophy in DMD rats. ( a ) Quantification of mRNA levels of senescence markers (p16, p19, and p21) in vehicle- and ABT263-treated rats (n = 7, 9). ( b ) In situ hybridisation of CDKN2A mRNA using RNAscope on TA muscle sections from vehicle- or ABT263-treated rats, with CDKN2A mRNA appearing as red dots. The white arrowheads show the CDKN2A mRNA + cells. Scale bar = 50 μm. ( c ) Quantification of the number of CDKN2A mRNA positive mononucleated cells per section from vehicle- or ABT263-treated rats. ( d ) Body weight comparison before and after treatment with vehicle (left panel) or ABT263 (right panel) (n = 7, 9). ( e ) Quantification of maximum muscle strength by grip test before and after treatment with vehicle (left panel) or ABT263 (right panel) (n = 7, 9). ( f ) Immunoblotting analysis of perilipin expression in vehicle- and ABT263-treated rats. Full-length blots are presented in Supplementary Figure a. ( g ) Quantification of perilipin protein expression (n = 7, 9). ( h ) Masson Trichrome stains of TA muscles from vehicle and ABT263-treated rats. Scale bar = 100 μm. ( i ) Quantification of Masson Trichrome staining positive area per section (n = 7, 9). ( j ) Immunohistochemical analysis of eMHC in TA muscle sections from vehicle- and ABT263-treated rats. Scale bar = 100 μm. ( k ) Quantification of eMHC positive fibres per section (n = 7, 9). ( l , m ) Quantification of ( l ) Pax7 + cells and ( m ) MyoD + cells of skeletal muscle primary cells from vehicle- and ABT263-treated rats (n = 7, 9). ( n ) Quantification of mRNA levels of SASP markers (IL-6, TGF-β 1 , IL-1β, CTGF, and MMP2) in vehicle- and ABT263-treated rats (n = 7, 9). Data are expressed as mean ± SEM. The p-value was determined by paired Student’s t test for ( d ) and ( e ), and unpaired Student’s t test for others. *p < 0.05, **p < 0.01. n.s. not significant.

Journal: Scientific Reports

Article Title: Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy

doi: 10.1038/s41598-020-73315-6

Figure Lengend Snippet: Senolytic drug ABT263 inhibits the exacerbation of muscular dystrophy in DMD rats. ( a ) Quantification of mRNA levels of senescence markers (p16, p19, and p21) in vehicle- and ABT263-treated rats (n = 7, 9). ( b ) In situ hybridisation of CDKN2A mRNA using RNAscope on TA muscle sections from vehicle- or ABT263-treated rats, with CDKN2A mRNA appearing as red dots. The white arrowheads show the CDKN2A mRNA + cells. Scale bar = 50 μm. ( c ) Quantification of the number of CDKN2A mRNA positive mononucleated cells per section from vehicle- or ABT263-treated rats. ( d ) Body weight comparison before and after treatment with vehicle (left panel) or ABT263 (right panel) (n = 7, 9). ( e ) Quantification of maximum muscle strength by grip test before and after treatment with vehicle (left panel) or ABT263 (right panel) (n = 7, 9). ( f ) Immunoblotting analysis of perilipin expression in vehicle- and ABT263-treated rats. Full-length blots are presented in Supplementary Figure a. ( g ) Quantification of perilipin protein expression (n = 7, 9). ( h ) Masson Trichrome stains of TA muscles from vehicle and ABT263-treated rats. Scale bar = 100 μm. ( i ) Quantification of Masson Trichrome staining positive area per section (n = 7, 9). ( j ) Immunohistochemical analysis of eMHC in TA muscle sections from vehicle- and ABT263-treated rats. Scale bar = 100 μm. ( k ) Quantification of eMHC positive fibres per section (n = 7, 9). ( l , m ) Quantification of ( l ) Pax7 + cells and ( m ) MyoD + cells of skeletal muscle primary cells from vehicle- and ABT263-treated rats (n = 7, 9). ( n ) Quantification of mRNA levels of SASP markers (IL-6, TGF-β 1 , IL-1β, CTGF, and MMP2) in vehicle- and ABT263-treated rats (n = 7, 9). Data are expressed as mean ± SEM. The p-value was determined by paired Student’s t test for ( d ) and ( e ), and unpaired Student’s t test for others. *p < 0.05, **p < 0.01. n.s. not significant.

Article Snippet: Then, the samples were hybridised with RNAscope Probe-Rn-CDKN2A (for rat samples; Cosmo Bio) or RNAscope Probe-Hs-CDKN2A (for human samples; Cosmo Bio) for 2 h, and signals were amplified with AMP1 to 6 (Cosmo Bio).

Techniques: In Situ, Hybridization, Western Blot, Expressing, Staining, Immunohistochemical staining

Senescence markers were elevated in human DMD patients. ( a – c ) Quantification of mRNA levels of senescence markers (p16, p14, and p21) in non-DMD control individuals and patients with DMD. Individual data from non-DMD control individuals and DMD patients are expressed as bar graphs (n = 10, 35). The grey band behind the graph indicates the mean ± SEM value range of the non-DMD control group. The figure without a grey band indicate that the target gene expression was not observed in the non-DMD control group. ( d , e ) Skeletal muscle sections from DMD patients were subjected to in situ hybridisation of CDKN2A mRNA using RNAscope before immunocytochemical analysis of ( d ) Pax7 or ( e ) PDGFRα with laminin. CDKN2A mRNA appears as brown dots. Scale bar = 10 μm. White arrowheads indicate DAB signal. N.D. not detected.

Journal: Scientific Reports

Article Title: Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy

doi: 10.1038/s41598-020-73315-6

Figure Lengend Snippet: Senescence markers were elevated in human DMD patients. ( a – c ) Quantification of mRNA levels of senescence markers (p16, p14, and p21) in non-DMD control individuals and patients with DMD. Individual data from non-DMD control individuals and DMD patients are expressed as bar graphs (n = 10, 35). The grey band behind the graph indicates the mean ± SEM value range of the non-DMD control group. The figure without a grey band indicate that the target gene expression was not observed in the non-DMD control group. ( d , e ) Skeletal muscle sections from DMD patients were subjected to in situ hybridisation of CDKN2A mRNA using RNAscope before immunocytochemical analysis of ( d ) Pax7 or ( e ) PDGFRα with laminin. CDKN2A mRNA appears as brown dots. Scale bar = 10 μm. White arrowheads indicate DAB signal. N.D. not detected.

Article Snippet: Then, the samples were hybridised with RNAscope Probe-Rn-CDKN2A (for rat samples; Cosmo Bio) or RNAscope Probe-Hs-CDKN2A (for human samples; Cosmo Bio) for 2 h, and signals were amplified with AMP1 to 6 (Cosmo Bio).

Techniques: Expressing, In Situ, Hybridization